Shine On You Crazy ...
Health Care: Health Services
Opko Health Inc. (OPK: NYSE)
$6.94 -0.06 | -0.86%
05/21/13 - 04:01 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 6.94 |
| 52 Week High | 7.83 |
| 52 Week Low | 4.00 |
| Avg. Daily Vol. (Mil) | 1.78 |
| Beta (3 year) | 1.28 |
| Share Related Items | |
| Mkt Cap (Mil) | 2,336.96 |
| Shares Out (Mil) | 336.74 |
| Float (Mil) | 156.69 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 3.50 |
| Current Ratio | 4.10 |
| LT Debt/ Equity | 0.80 |
| Total Debt / Equity | 0.87 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 33.56 |
| Price/Book | 7.28 |
| Price/Cash Flow | -50.40 |
| Per Share Data | |
| Earnings | -0.19 |
| Sales | 0.21 |
| Book Value | 0.95 |
| Cash Flow | -0.14 |
| Business Summary | |
|---|---|
| Opko Health, Inc. is a biopharmaceutical and diagnostics company, engaged in the development and commercialization of pharmaceutical products, vaccines, diagnostic technologies, and imaging systems. | |
| General Information | |
| 4400 Biscayne Boulevard
Miami, FL 33137 |
|
| www.opko.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 549 | |
| CEO: Dr. Phillip Frost,M.D. | |
| Short Interest | |
| Current Month (Mil) | 29.39 |
| Previous Month (Mil) | 28.91 |
| Short Interest Ratio (Days) | 16.30 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -8.50 |
| Return on Investments | -9.60 |
| Profitability | |
| Gross Margin | 53.60 |
| EBIT Margin | -88.50 |
| Profit Margin | -80.00 |
Portfolios with OPK
- Portfolio NameUser Type
- Usercdm1
- ContributorTechnical Setups for the We...
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- UserBasement money
- ContributorStocks With Big Insider Buy...
- UserTerry
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
Latest OPK Headlines from TheStreet
- Interesting OPK Put And Call For July 05.20.13 | 06:05 pm
- 'Mad Money' Lightning Round: Buy AOL Now 05.15.13 | 06:05 am
- Cramer's 'Mad Money' Recap: Stick With What Works 05.14.13 | 08:05 pm
- TheStreet Ratings Top 10 Rating Changes 05.06.13 | 04:05 pm
- Opko Health Enters Oversold Territory (OPK) 05.01.13 | 12:05 pm
- Opko Health Inc. Stock Downgraded (OPK) 05.01.13 | 05:05 am
- Top Insider Trades: SPB, OPK, MSFT, BERY 04.26.13 | 07:04 am
- TheStreet Ratings Top 10 Rating Changes 04.08.13 | 09:04 am
- Cramer's Top Stock Picks: ARCP OPK EXAS 04.06.13 | 06:04 am
- Cramer's 'Mad Money' Recap: Next Week's Game Plan 04.05.13 | 07:04 pm
Press Releases for OPK
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of PROLOR Biotech, Inc. In Connection With The Sale Of The Company To OPKO Health, Inc. - PR Newswire 04.29.13 | 01:04 pm
- Acquisition Of PROLOR Biotech, Inc. By OPKO Health, Inc. May Not Be In The Best Interests Of PROLOR Shareholders - PR Newswire 04.24.13 | 08:04 pm
- Management Buyout Of PROLOR - Law Firm Seeks Higher Price For Shareholders - PR Newswire 04.24.13 | 10:04 am
- RXi Pharmaceuticals And OPKO Health Announce Strategic Pooling Of RNAi Assets - Business Wire 03.07.13 | 08:03 am
- RXi Pharmaceuticals Announces $16.4 Million Placement Of Common Stock - Business Wire 03.07.13 | 08:03 am
- RXi Pharmaceuticals And OPKO Health Announce Strategic Pooling Of RNAi Assets - Business Wire 03.07.13 | 08:03 am
- OPKO Health Completes Acquisition Of Two Phase 3 Products - Business Wire 03.04.13 | 04:03 pm
- OPKO Point-of-Care Technology Demonstrated On Mobile Device With Cloud Connectivity To Diagnose And Track Disease In Africa - Business Wire 03.01.13 | 08:03 am
- OPKO Health Completes Acquisition Of Brazilian Pharmaceutical Company - Business Wire 02.15.13 | 04:02 pm
- OPKO Closes Offering Of $175 Million Of 3.00% Convertible Senior Notes Due 2033 - Business Wire 01.31.13 | 08:01 am
Partner Headlines for OPK
- Near-Term Catalysts And High Insider Ownership Make GTx An Attractive Buy - Seeking Alpha 05.07.13 | 09:05 am
- Starbucks, Huntington Bancshares and Other Stocks Insiders Are Buying - Benzinga 05.04.13 | 10:05 am
- OPKO Health Acquires Interest in Growing Russian Pharmaceutical Company - Benzinga 04.18.13 | 09:04 am
- Apache, Windstream and Other Stocks Insiders Are Buying - Benzinga 04.06.13 | 12:04 pm
- Moves in Smaller Health Care Stocks (ANAC, HALO, PBYI, QCOR) - Benzinga 03.23.13 | 11:03 am
- Icahn Enterprises, Sears Holdings and Other Stocks Insiders Are Buying - Benzinga 03.09.13 | 02:03 pm
- Insiders Love These 3 Highly Shorted Healthcare Stocks - Seeking Alpha 01.23.13 | 09:01 am
- BlackRock, Cracker Barrel and Other Stocks Insiders Are Buying - Benzinga 10.23.12 | 01:10 pm
- 3 Best Biotech Stocks For This Week (Part VI) - Seeking Alpha 10.16.12 | 08:10 am
- 5 Stocks With Insider Buys Filed On October 5 To Consider - Seeking Alpha 10.06.12 | 05:10 am
